A Model of the Ventilatory Depressant Potency of Remifentanil in the Non–steady State
Open Access
- 1 October 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 99 (4) , 779-787
Abstract
Background: The C50 of remifentanil for ventilatory depression has been previously determined using inspired carbon dioxide and stimulated ventilation, which may not describe the clinically relevant situation in which ventilatory depression occurs in the absence of inspired carbon dioxide. The authors applied indirect effect modeling to non-steady state Paco2 data in the absence of inspired carbon dioxide during and after administration of remifentanil. Methods: Ten volunteers underwent determination of carbon dioxide responsiveness using a rebreathing design, and a model was fit to the end-expiratory carbon dioxide and minute ventilation. Afterwards, the volunteers received remifentanil in a stepwise ascending pattern using a computer-controlled infusion pump until significant ventilatory depression occurred (end-tidal carbon dioxide [Peco2] > 65 mmHg and/or imminent apnea). Thereafter, the concentration was reduced to 1 ng/ml. Remifentanil pharmacokinetics and Paco2 were determined from frequent arterial blood samples. An indirect response model was used to describe the Paco2 time course as a function of remifentanil concentration. Results: The time course of hypercarbia after administration of remifentanil was well described by the following pharmacodynamic parameters: F (gain of the carbon dioxide response), 4.30; ke0 carbon dioxide, 0.92 min-1; baseline Paco2, 42.4 mmHg; baseline minute ventilation, 7.06 l/min; kel,CO2, 0.08 min-1; C50 for ventilatory depression, 0.92 ng/ml; Hill coefficient, 1.25. Conclusion: Remifentanil is a potent ventilatory depressant. Simulations demonstrated that remifentanil concentrations well tolerated in the steady state will cause a clinically significant hypoventilation following bolus administration, confirming the acute risk of bolus administration of fast-acting opioids in spontaneously breathing patients.Keywords
This publication has 13 references indexed in Scilit:
- Non–steady State Analysis of the Pharmacokinetic Interaction between Propofol and RemifentanilAnesthesiology, 2002
- Einfluss von Anästhetika auf die AtemkontrolleDer Anaesthesist, 2002
- Response Surface Modeling of Alfentanil-Sevoflurane Interaction on Cardiorespiratory Control and Bispectral IndexAnesthesiology, 2001
- The Pharmacodynamic Effect of a Remifentanil Bolus on Ventilatory ControlAnesthesiology, 2000
- Pharmacokinetic-Pharmacodynamic Modeling of the Respiratory Depressant Effect of AlfentanilAnesthesiology, 1999
- Determination of the Potency of Remifentanil Compared with Alfentanil Using Ventilatory Depression as the Measure of Opioid EffectAnesthesiology, 1999
- Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of RemifentanilAnesthesiology, 1997
- Opioid pharmacodynamics in neonatal dogs: differences between morphine and fentanylJournal of Applied Physiology, 1995
- Pronounced, Episodic Oxygen Desaturation in the Postoperative PeriodAnesthesiology, 1985
- A CLINICAL METHOD FOR ASSESSING THE VENTILATORY RESPONSE TO CARBON DIOXIDEAustralasian Annals of Medicine, 1967